PL356220A1 - DNA kodujący nowy polipeptyd RGI - Google Patents

DNA kodujący nowy polipeptyd RGI

Info

Publication number
PL356220A1
PL356220A1 PL00356220A PL35622000A PL356220A1 PL 356220 A1 PL356220 A1 PL 356220A1 PL 00356220 A PL00356220 A PL 00356220A PL 35622000 A PL35622000 A PL 35622000A PL 356220 A1 PL356220 A1 PL 356220A1
Authority
PL
Poland
Prior art keywords
polypeptides
polypeptide
methods
encoding
polynucleotides
Prior art date
Application number
PL00356220A
Other languages
English (en)
Other versions
PL207634B1 (pl
Inventor
Richard Harkins
Deborah Parkes
Gordon Parry
Douglas W. Schneider
Renate Steinbrecher
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL356220A1 publication Critical patent/PL356220A1/pl
Publication of PL207634B1 publication Critical patent/PL207634B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
PL356220A 1999-12-16 2000-12-15 Wyizolowane przeciwciało, immunokoniugat i jego zastosowanie PL207634B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17237099P 1999-12-16 1999-12-16
US09/732,357 US6682902B2 (en) 1999-12-16 2000-12-07 DNA encoding a novel RG1 polypeptide
PCT/US2000/033901 WO2001044291A2 (en) 1999-12-16 2000-12-15 Polynucleotid encoding the rg1 polypeptide

Publications (2)

Publication Number Publication Date
PL356220A1 true PL356220A1 (pl) 2004-06-28
PL207634B1 PL207634B1 (pl) 2011-01-31

Family

ID=26868022

Family Applications (1)

Application Number Title Priority Date Filing Date
PL356220A PL207634B1 (pl) 1999-12-16 2000-12-15 Wyizolowane przeciwciało, immunokoniugat i jego zastosowanie

Country Status (32)

Country Link
US (5) US6682902B2 (pl)
EP (2) EP1237915B1 (pl)
JP (1) JP4979867B2 (pl)
KR (1) KR100752434B1 (pl)
CN (1) CN1297566C (pl)
AT (1) ATE440862T1 (pl)
AU (1) AU784674B2 (pl)
BG (1) BG65898B1 (pl)
BR (1) BR0017022A (pl)
CA (1) CA2394574A1 (pl)
CZ (1) CZ299232B6 (pl)
DE (1) DE60042836D1 (pl)
DK (1) DK1237915T3 (pl)
EE (1) EE05293B1 (pl)
ES (1) ES2331106T3 (pl)
HR (1) HRP20020549B1 (pl)
HU (1) HU229001B1 (pl)
IL (2) IL150115A0 (pl)
LT (1) LT5046B (pl)
ME (1) MEP37808A (pl)
MX (1) MXPA02005914A (pl)
NO (1) NO330924B1 (pl)
NZ (1) NZ519598A (pl)
PL (1) PL207634B1 (pl)
PT (1) PT1237915E (pl)
RO (1) RO122543B1 (pl)
RS (1) RS50831B (pl)
RU (1) RU2283130C2 (pl)
SI (2) SI1237915T1 (pl)
SK (2) SK288147B6 (pl)
WO (1) WO2001044291A2 (pl)
ZA (1) ZA200205638B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020161199A1 (en) * 1998-04-08 2002-10-31 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
EP1251139A3 (en) * 1998-04-08 2002-12-18 Genentech, Inc. Human mindin-like protein and nucleic acids encoding it
US6960433B1 (en) 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20070031901A1 (en) * 1999-03-08 2007-02-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide
JP4680902B2 (ja) 2003-07-22 2011-05-11 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト Ｒｇ１抗体及びその使用
US7294704B2 (en) * 2003-08-15 2007-11-13 Diadexus, Inc. Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk
US7785591B2 (en) 2004-10-14 2010-08-31 Morphosys Ag Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
TWI615403B (zh) * 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
MX2010005683A (es) * 2007-11-30 2010-06-11 Bristol Myers Squibb Co Conjugados de anticuerpos anti-rg-1.
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CN102346184B (zh) * 2010-08-03 2014-03-26 中国人民解放军军事医学科学院生物工程研究所 Spon2的新用途
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5437994A (en) 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
EP0641212A4 (en) 1992-05-14 1997-05-21 Ribozyme Pharm Inc PROCESS AND REAGENT FOR PREVENTING THE DEVELOPMENT OF CANCER.
US5871969A (en) 1996-02-12 1999-02-16 Human Genome Sciences, Inc. Nucleic acids encoding human neuronal attachment factor-1
US6177244B1 (en) * 1996-05-10 2001-01-23 Beth Israel Deaconess Medical Center Inc. NPG-1 gene that is differentially expressed in prostate tumors
US5804382A (en) 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US6287777B1 (en) * 1996-05-10 2001-09-11 Beth Israel Deaconess Medical Center NPG-1 gene that is differentially expressed in prostate tumors
JP3494529B2 (ja) * 1996-06-06 2004-02-09 Ｙｋｋ株式会社 一体成形面ファスナー
WO1998008381A1 (en) * 1996-08-26 1998-03-05 University Of Washington Therapeutic and diagnostic applications of perlecan domain i splice variants
WO1999046281A2 (en) 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same
WO1998045442A2 (en) 1997-04-10 1998-10-15 Zymogenetics, Inc. Secreted f-spondin homologs
EP0981625A2 (en) * 1997-05-06 2000-03-01 Human Genome Sciences, Inc. $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
AU7376698A (en) 1997-05-09 1998-11-27 Smithkline Beecham Corporation Integrin ligand, human mindin
US6166176A (en) * 1998-03-17 2000-12-26 Immvarx, Inc. Cancer marker protein and peptides thereof
US6960433B1 (en) * 1998-10-19 2005-11-01 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1126877A4 (en) 1998-10-19 2003-05-28 Diadexus Inc METHOD OF DIAGNOSIS, MONITORING, STADIUM CLASSIFICATION, VISUALIZATION AND TREATMENT OF PROSTATE CANCER
EE05627B1 (et) * 1998-12-23 2013-02-15 Pfizer Inc. CTLA-4 vastased inimese monoklonaalsed antikehad
US6824780B1 (en) * 1999-10-29 2004-11-30 Genentech, Inc. Anti-tumor antibody compositions and methods of use
US6682902B2 (en) * 1999-12-16 2004-01-27 Schering Aktiengesellschaft DNA encoding a novel RG1 polypeptide

Also Published As

Publication number Publication date
BR0017022A (pt) 2002-11-05
EE05293B1 (et) 2010-04-15
WO2001044291A2 (en) 2001-06-21
KR100752434B1 (ko) 2007-08-27
EP2048157A1 (en) 2009-04-15
SI21140A (sl) 2003-08-31
PL207634B1 (pl) 2011-01-31
JP4979867B2 (ja) 2012-07-18
LT2002070A (en) 2003-04-25
NO330924B1 (no) 2011-08-22
PT1237915E (pt) 2009-11-04
RS50831B (sr) 2010-08-31
CN1434832A (zh) 2003-08-06
SK286384B6 (sk) 2008-08-05
HUP0204224A2 (hu) 2003-03-28
LT5046B (lt) 2003-08-25
YU44602A (sh) 2005-06-10
SI1237915T1 (sl) 2009-12-31
BG65898B1 (bg) 2010-04-30
WO2001044291A3 (en) 2002-01-17
US20040023307A1 (en) 2004-02-05
SK8482002A3 (en) 2003-02-04
MXPA02005914A (es) 2003-02-27
EP1237915B1 (en) 2009-08-26
MEP37808A (en) 2011-05-10
DE60042836D1 (de) 2009-10-08
EE200200323A (et) 2003-10-15
AU784674B2 (en) 2006-05-25
RU2283130C2 (ru) 2006-09-10
NO20022836L (no) 2002-08-15
SK288147B6 (sk) 2013-12-02
EP1237915A2 (en) 2002-09-11
US6682902B2 (en) 2004-01-27
NO20022836D0 (no) 2002-06-14
NZ519598A (en) 2004-03-26
ES2331106T3 (es) 2009-12-22
CN1297566C (zh) 2007-01-31
ZA200205638B (en) 2003-10-15
HUP0204224A3 (en) 2004-12-28
US7893217B2 (en) 2011-02-22
HRP20020549B1 (hr) 2013-09-30
IL150115A (en) 2013-11-28
US20090292112A1 (en) 2009-11-26
US20020004047A1 (en) 2002-01-10
RO122543B1 (ro) 2009-08-28
KR20020065575A (ko) 2002-08-13
US20090214422A1 (en) 2009-08-27
EP2048157B1 (en) 2012-10-10
DK1237915T3 (da) 2009-11-16
AU3074601A (en) 2001-06-25
CA2394574A1 (en) 2001-06-21
CZ299232B6 (cs) 2008-05-21
HRP20020549A2 (en) 2004-04-30
RU2002119208A (ru) 2004-02-27
JP2003521244A (ja) 2003-07-15
US7307154B2 (en) 2007-12-11
ATE440862T1 (de) 2009-09-15
US7887804B2 (en) 2011-02-15
HU229001B1 (en) 2013-07-29
IL150115A0 (en) 2002-12-01
US20040152139A1 (en) 2004-08-05
BG106823A (bg) 2003-04-30

Similar Documents

Publication Publication Date Title
ZA200205638B (en) Polynucleotid encoding the RG1 polypeptide.
WO1998031800A3 (en) Human proteins
NZ334721A (en) Purified human alpha-galactosidase A and therapeutic use
AU5258898A (en) Mutant forms of fas ligand and uses thereof
DE69935220D1 (de) Von menschlichem tumor stammendes polypeptidhormon phosphatonin
BR9910396A (pt) Polinucleotìdeo(s) e polipeptìdeos basb029 a partirde neisseria meningitidis
NO20011460L (no) Cytokinreseptor zalphall
WO2000073323A3 (en) Adam polynucleotides and polypeptides
WO2001008635A3 (en) Calcium channel transport polynucleotides, polypeptides, and antibodies
WO2001081577A3 (en) Dna encoding the prost 03 polypeptide
NZ516237A (en) Meth1 and meth2 polynucleotides and polypeptides
WO2003029423A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2000061774A3 (en) Bone morphogenic proteins
JP2004513615A5 (pl)
DE59109085D1 (de) Epididymis-spezifische Polypeptide und deren Verwendung
MY127669A (en) Polypeptide hormone phosphatonin
GB0120022D0 (en) Conjugate
ATE368740T1 (de) Die menschliche beta-1a-untereinheit des potential-abhängigen natriumkanals und deren verwendungen
WO2001042472A3 (en) DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE
WO1998029438A3 (en) Cortistatin polypeptides
WO2003031586A3 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
PT1673391E (pt) Cdna modificado para elevados níveis de expressão do factor viii e dos seus derivados
WO2000042165A3 (en) Bone marrow-specific protein
WO2002102319A3 (en) Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue
WO2000071567A3 (en) Fibroblast growth factor 13